ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GDR Genedrive Plc

2.25
0.00 (0.00%)
28 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.25 2.20 2.30 2.25 2.25 2.25 1,451,687 07:48:42
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -2.37 12.22M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 2.25p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 11.85p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £12.22 million. Genedrive has a price to earnings ratio (PE ratio) of -2.37.

Genedrive Share Discussion Threads

Showing 32201 to 32215 of 33675 messages
Chat Pages: Latest  1299  1298  1297  1296  1295  1294  1293  1292  1291  1290  1289  1288  Older
DateSubjectAuthorDiscuss
17/9/2024
08:42
Shares will rise 50% to 100% upon news of further contract wins and or EVA for MT-RNR1
z1co
17/9/2024
08:30
Zico is not only a liar, he's a little guy from a bedsit trading in chunks of £100.

I politely asked him which trades were his, and when I was closing my shorts, he refused to me (even though he claimed he was buying big). With high sight, I should have kept my big shorts till 0.5p

jane1984
17/9/2024
08:26
Did Zico pass my shorts closure as long as "millions of shares"? Yes he did.

Now that GDR is cheaper, he should buy 5m shares and tell us 5 minutes in advance.

jane1984
17/9/2024
07:54
Beeksy

You muppet why don't you just keep posting on the other FRED.

z1co
17/9/2024
07:46
Jane , LOL

I have more than enough and if i want to buy more i will.

I'm not LIAR like you buying shares at around 2.80p and then posting they were shorts.

So why don't you kindly get yourself fkd.

Hope that helps you

z1co
17/9/2024
07:28
Why does Zico not buy the millions now and tell us he is buying? Rather passing other people's trades as his.

Show us he does not trade in chunk of £100

jane1984
17/9/2024
06:53
The Labour government are making NHS their number one priority.

hxxps://news.sky.com/story/junior-doctors-vote-to-accept-pay-deal-13216267

themachine2
17/9/2024
06:47
The CYP2C19-ID Kit was only approved on 31/07/2024 and withing two weeks the company won initial orders in excess of £100,000 with Greater Manchester's Comprehensive Stroke Centre.

Over the coming weeks/months more NHS hospitals will implement the test.

z1co
17/9/2024
06:43
KIngston posting LIES yet again.

By implementing CYP2C19 genotyping in IS/TIA the NHS could save approximately £91m and £454m over one and five years respectively.

z1co
17/9/2024
01:59
The share price is hanging by a thread, but the thread will break. As soon as it falls below 2 p it will quickly drop to 1.5 p (the previous placing price). Investors are aware that there is only a sales order of £100k. I reckon that the company will announce the next placing at 1 p a share in March 2025 before the cash runs out.

Those talking of savings for the NHS if it uses GDR's devices are too optimistic. The real world does not operate like that. Essentially, the NHS is spreading its resources too thinly on too many things.

kingston78
16/9/2024
11:36
A few more contract wins will see the price rise to over 4p again.
themachine2
16/9/2024
11:32
Wrong thread , you wanna be ramping your losses at GEX , it's nearly 10p now.!

Be a nice troll and hop along.

themachine2
16/9/2024
11:12
put a sock in it for gods sake
purple11
16/9/2024
11:11
Dr Gino Miele, CEO of genedrive plc, said after winning 1st orders for CYP2C19 Kit:

"These initial first-sales of our CYP2C19 ID-kit in the UK to one of the largest stroke centres nationally is a key initial milestone in our CYP2C19 commercialisation strategy, and further strengthens our pharmacogenetic positioning strategy in emergency care more broadly. We look forward to increasing implementation of our CYP2C19 test in the UK NHS and internationally to the benefit of both healthcare systems financially and improvement of patient outcomes."

z1co
16/9/2024
11:05
By implementing CYP2C19 genotyping in IS/TIA the NHS could save approximately £91m and £454m over one and five years respectively.
z1co
Chat Pages: Latest  1299  1298  1297  1296  1295  1294  1293  1292  1291  1290  1289  1288  Older

Your Recent History

Delayed Upgrade Clock